Influenza in Canada, 2012-2013 season.

Objective This report summarizes influenza activity in Canada during the 2012-13 influenza season (August 26, 2012-August 24, 2013) from data obtained through the FluWatch surveillance program. Methods FluWatch collected information from six primary indicators of influenza activity that describe the epidemiologic and virologic behaviour of influenza in Canada: sentinel laboratory-based influenza detections; strain characterization and antiviral resistance for circulating influenza viruses; primary care consultation rates of influenza-like illness; regional influenza activity levels; influenza-associated severe outcomes; and pharmacy surveillance. Results The influenza season peaked nationally between late December 2012 and early January 2013 with influenza A(H3N2) identified as the predominant circulating influenza strain until early March, when influenza B became the predominant circulating strain. The cumulative reported hospitalization rates for all age groups were 25.0 per 100,000. Influenza A most greatly affected adults ≥65 years of age and influenza B most greatly affected children ≤19 years of age. Conclusion The influenza season was moderately severe. When compared to the previous two seasons, which were considered relatively mild, there was a significant increase in laboratory detections for influenza, as well as hospitalizations associated with influenza in 2012-13.

[1]  D. Skowronski,et al.  Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses , 2014, PloS one.

[2]  U. Buchholz,et al.  Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  D. Schanzer,et al.  Estimating Influenza Deaths in Canada, 1992–2009 , 2013, PloS one.

[4]  D. Skowronski,et al.  Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  D. Schanzer,et al.  Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for Canada , 2012, Influenza and other respiratory viruses.

[6]  Dena L. Schanzer,et al.  Role of influenza and other respiratory viruses in admissions of adults to Canadian hospitals , 2008, Influenza and other respiratory viruses.

[7]  D. Schanzer,et al.  Hospitalization Attributable to Influenza and Other Viral Respiratory Illnesses in Canadian Children , 2006, The Pediatric infectious disease journal.

[8]  Conjugate Meningococcal.  Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)†. , 2011, Canada communicable disease report = Releve des maladies transmissibles au Canada.